March 12, 2018 / 12:24 PM / 7 months ago

BRIEF-Dare Bioscience Announces Development And Option Agreement With Orbis Biosciences For Long-Acting Injectable Contraceptive

March 12 (Reuters) - Dare Bioscience Inc:

* DARÉ BIOSCIENCE ANNOUNCES EXCLUSIVE DEVELOPMENT AND OPTION AGREEMENT WITH ORBIS BIOSCIENCES FOR LONG-ACTING INJECTABLE CONTRACEPTIVE

* DARE BIOSCIENCE - AGREEMENT TERMS WITH ORBIS PROVIDE CO OPTION TO ENTER LICENSE AGREEMENT FOR ORB-204 & ORB-214 SHOULD DEVELOPMENT EFFORTS SUCCEED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below